Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 584 shares at $14.00 ($8K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($8k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |
| FDMT | SELL | 2025-12-19 | $18K | — | Filing → |